The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue

Anti-CD44 Antibody Treatment Lowers Hyperglycemia and Improves Insulin Resistance, Adipose Inflammation, and Hepatic Steatosis in Diet-Induced Obese Mice

(2014) Keiichi Kodama et al.   DIABETES

CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance

(2013) Hong Soon Kang et al.   PLoS One

CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model

(2013) Charlotte E. Egan et al.   PLoS One

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes

(2012) K. Kodama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function

(2011) Maximilian Zeyda et al.   ENDOCRINOLOGY

Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance

(2010) F. W. Kiefer et al.   DIABETES

Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity

(2010) J. M. Wentworth et al.   DIABETES

Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity

(2008) A. Bertola et al.   DIABETES

Osteopontin Expression in Human and Murine Obesity: Extensive Local Up-Regulation in Adipose Tissue but Minimal Systemic Alterations

(2007) Florian W. Kiefer et al.   ENDOCRINOLOGY